Torben V. Borchert
European Bioinformatics Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Torben V. Borchert.
FEBS Letters | 1994
Torben V. Borchert; M Mathieu; J.Ph. Zeelen; S.A. Courtneidge; Rik K. Wierenga
SH3 domains are modules occurring in diverse proteins, ranging from cytoskeletal proteins to signaling proteins, such as tyrosine kinases. The crystal structure of the SH3 domain of Csk (c‐Src specific tyrosine kinase) has been refined at a resolution of 2.5 Å, with an R‐factor of 22.4%. The structure is very similar to the FynSHS crystal structure. When comparing CskSHS and FynSH3 it is seen that the structural and charge differences of the RT‐Src loop and the n‐Src loop, near the conserved Trp47, correlate with different binding properties of these SH3 domains. The structure comparison suggests that those glycines and acid residues which are very well conserved in the SH3 sequences are important for the stability of the SH3 fold.
Structure | 1995
Torben V. Borchert; Kv Radha Kishan; Johan Ph Zeelen; Wolfgang Schliebs; Narmada Thanki; Ruben Abagyan; Rainer Jaenicke; Rik K. Wierenga
BACKGROUND Wild-type triosephosphate isomerase (TIM) is a very stable dimeric enzyme. This dimer can be converted into a stable monomeric protein (monoTIM) by replacing the 15-residue interface loop (loop-3) by a shorter, 8-residue, loop. The crystal structure of monoTIM shows that two active-site loops (loop-1 and loop-4), which are at the dimer interface in wild-type TIM, have acquired rather different structural properties. Nevertheless, monoTIM has residual catalytic activity. RESULTS Three new structures of variants of monoTIM are presented, a double-point mutant crystallized in the presence and absence of bound inhibitor, and a single-point mutant in the presence of a different inhibitor. These new structures show large structural variability for the active-site loops, loop-1, loop-4 and loop-8. In the structures with inhibitor bound, the catalytic lysine (Lys13 in loop-1) and the catalytic histidine (His95 in loop-4) adopt conformations similar to those observed in wild-type TIM, but very different from the monoTIM structure. CONCLUSIONS The residual catalytic activity of monoTIM can now be rationalized. In the presence of substrate analogues the active-site loops, loop-1, loop-4 and loop-8, as well as the catalytic residues, adopt conformations similar to those seen in the wild-type protein. These loops lack conformational flexibility in wild-type TIM. The data suggest that the rigidity of these loops in wild-type TIM, resulting from subunit-subunit contacts at the dimer interface, is important for optimal catalysis.
FEBS Letters | 1995
Torben V. Borchert; J.Ph. Zeelen; Wolfgang Schliebs; Mia Callens; W. Minke; Rainer Jaenicke; Rik K. Wierenga
Wild‐type trypanosomal triosephosphate isomerase (wtTIM) is a very tight dimer. The interface residue His‐47 of wtTIM has been mutated into an asparagine. Ultracentrifugation data show that this variant (H47N) only dimerises at protein concentrations above 3 mg/ml. H47N has been characterised at a protein concentration where it is predominantly a monomer. Circular dichroism measurements in the near‐UV and far‐UV show that this monomer is a compactly folded protein with secondary structure similar as in wtTIM. The thermal stability of the monomeric H47N is decreased compared to wtTIM: temperature gradient gel electrophoresis (TGGE) measurements give T m‐values of 41°C for wtTIM, whereas the T m‐value for the monomeric form of H47N is approximately 7°C lower.
Proceedings of the National Academy of Sciences of the United States of America | 1994
Torben V. Borchert; Ruben Abagyan; Rainer Jaenicke; Rik K. Wierenga
Protein Engineering | 2001
Jens Erik Nielsen; Torben V. Borchert; Gerrit Vriend
FEBS Journal | 1993
Torben V. Borchert; Kathryn Pratt; Johan Ph Zeelen; Mia Callens; Martin Noble; Fred R. Opperdoes; Paul A. M. Michels; Rik K. Wierenga
Protein Science | 2008
K. V. Kishan; Johan Ph Zeelen; Martin Noble; Torben V. Borchert; Rik K. Wierenga
Protein Engineering | 1993
Véronique Mainfroid; Karine Goraj; Françoise Rentier-Delrue; Annick Houbrechts; A. Loiseau; A. C. Gohimont; Martin Noble; Torben V. Borchert; Rik K. Wierenga; Joseph Martial
Biochemistry | 2012
Damien Farrell; Helen M. Webb; Michael Johnston; Thomas Agersten Poulsen; Fergal O’Meara; Lars H. Christensen; Lars Beier; Torben V. Borchert; Jens Erik Nielsen
Protein Engineering | 1994
Radha Kishan; Ph. Johan Zeelen; Martin Noble; Torben V. Borchert; Véronique Mainfroid; Karine Goraj; Joseph Martial; Rik K. Wierenga